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Abstract
Background: Coxiella burnetii contains the IS1111 transposase which is present 20 times in the
Nine Mile phase I (9Mi/I) genome. A single PCR primer that binds to each IS element, and primers
specific to a region ~500-bp upstream of each of the 20 IS1111 elements were designed. The
amplified products were characterized and used to develop a repetitive element PCR genotyping
method.
Results: Isolates Nine Mile phase II, Nine Mile RSA 514, Nine Mile Baca, Scottish, Ohio, Australian
QD, Henzerling phase I, Henzerling phase II, M44, KAV, PAV, Q238, Q195 and WAV were tested
by PCR and compared to 9Mi/I. Sequencing was used to determine the exact differences in isolates
which lacked specific IS elements or produced PCR products of differing size. From this data, an
algorithm was created utilizing four primer pairs that allows for differentiation of unknown isolates
into five genomic groups. Additional isolates (Priscilla Q177, Idaho Q, Qiyi, Poker Cat, Q229 and
Q172) and nine veterinary samples were characterized using the algorithm which resulted in their
placement into three distinct genomic groups.
Conclusion: Through this study significant differences, including missing elements and sequence
alterations within and near IS element coding regions, were found between the isolates tested.
Further, a method for differentiation of C. burnetii isolates into one of five genomic groups was
created. This algorithm may ultimately help to determine the relatedness between known and
unknown isolates of C. burnetii.
Background
Coxiella burnetii is a gram-negative, obligate, intracellular
bacterium that causes Q fever in humans. Infection occurs
through inhalation of contaminated aerosols and fewer
then ten organisms is sufficient to seed an infection [1]. Q
fever can manifest as an acute infection characterized by a
flu-like febrile illness, headache, and atypical pneumonia
and the recommended treatment is doxycycline. A chronic
infection is typified by endocarditis and/or hepatitis with
poor prognosis [2].
Initial studies examining restriction fragment length poly-
morphisms (RFLP) in chromosomal and plasmid DNA
from seven C. burnetii isolates revealed genetic heteroge-
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neity among the isolates [3]. In subsequent research, RFLP
patterns analyzed via sodium dodecyl sulfate-polyacryla-
mide [4] or pulsed field gel electrophoresis [5] allowed for
the creation of six distinct genomic groups (I through VI).
Isolates from acute disease patients could be placed in
genomic groups I, II and III, while groups IV and V con-
tained isolates from chronic disease patients. Further-
more, isolates placed in genomic groups I, II and III were
shown to contain the plasmid QpH1, group IV isolates to
contain the plasmid QpRS, and group V isolates are plas-
midless [5], though QpRS-homologous sequences are
located in chromosomal genome sequences of the group
V isolates [6,7]. The group VI isolates were initially
reported to contain the plasmid QpDG, though newer
experiments suggest these may actually possess QpH1,
and QpDG containing isolates were shown to be avirulent
in guinea pigs [8,9]. Additional studies have characterized
a variety of isolates using RFLP/pulsed field gel electro-
phoresis with differing restriction enzymes [10], multi-
spacer sequence typing [11], multiple loci variable
number of tandem repeats analysis [12,13], and microar-
rays [14] which have discriminated isolates into as many
as 36 distinct genotypes.
With the completion of the genome sequence of Nine
Mile Phase I (9Mi/I), 20 unique copies of the IS1111
transposase were identified [15]. Previous work describ-
ing the insertion sequence noted that the coding region of
the transposase is bounded by two sets of terminal
inverted repeats at each end, which were previously
referred to as the inner and outer inverted repeats [16].
The inner inverted repeats are thought to represent the ter-
mini of the IS element. It is predicted that IS1111 forms a
circular intermediate, whereby the inner inverted repeats
are brought closer together to form a strong promoter
which increases transposase expression. The outer
inverted repeats are believed to be chromosomal
sequences which form a stem-loop structure that acts as a
recognition site for insertion of the IS element but are not
part of the IS element itself. This chromosomal target
sequence is present more than 50 times throughout the
9Mi/I genome [17]. Sequence differences in the various
copies of IS1111, most of which are present in the loop of
the stem-loop recognition site, led to its further subdivi-
sion into IS1111A, IS1111B and IS1111C [16]. We sought
to compare the locations of IS1111 in a variety of isolates
of C. burnetii to that of the 20 copies present in 9Mi/I
using a PCR-based method. Because of the high copy
number of the IS element in the C. burnetii genome and
the unique regions adjacent to each element, this has
proved to be a useful tool in differentiating isolates of C.
burnetii into groups, much like the six genomic groups
proposed previously [4,5]. We present an algorithm
which distinguishes members from five of the six genomic
groups using four primer pairs and a two-step PCR cycling
program.
Results
PCR analysis included 14 isolates, 10 of which had previ-
ously been characterized as members of genetic groupings
I through V [Nine Mile phase II (9Mi/II), Nine Mile RSA
514 (RSA 514), Ohio, Australian QD, Q195, Henzerling
RSA 343 (Henz I), Henzerling, RSA 331 (Henz II), M44,
KAV, PAV, Q238 and WAV], and 4 [Nine Mile Baca (9Mi/
Baca), Scottish, Q238 and WAV] which had not been gen-
otyped [4]. Our repository lacks the group VI Dugway iso-
lates, thus these were not included. The analysis was
completed for each isolate for each of the 20 IS elements
present in 9Mi/I using the consensus primer IS1111-1
paired with a unique primer upstream of each of the IS
elements. The presence or absence of certain IS elements
was generally consistent among members of a particular
genogroup, but allowed their differentiation from mem-
bers of other genogroups. The results from each of these
14 isolates are provided (see Additional file 1) along with
the element's orientation and nucleotide position in 9Mi/
I [GenBank: AE016828], and GenBank accession numbers
for the sequences determined in this study.
Genomic group I isolates
9Mi/II, RSA 514, Ohio, and Australian QD appeared to
have all 20 IS elements and their products were indistin-
guishable from each other and 9Mi/I by this method. The
isolates 9Mi/Baca and Scottish, which have not been gen-
otyped previously, also had all 20 IS elements and were
placed within this group.
Genomic group II isolates
PCR products amplified using DNA from isolates Henz I,
Henz II, and M44 were identical in size to 9Mi/I for 15 of
the 20 IS elements (2, 3, 5, 6, 7, 8, 9, 11, 12, 13, 15, 16,
17, 18, and 19). IS elements 14 and 20 were confirmed
absent in these isolates by sequencing, though our M44
isolate also possessed a subpopulation which contained
IS 14 (Fig 1). In regards to IS 14, the deletion totaled 1,374
bp, which corresponds exactly to the predicted length of
the IS element [17]. Also within this region, Henz I and
Henz II, but not M44, contain a point mutation. The IS 20
deletion in these three isolates totaled 2,246 bp.
Amplicons to IS elements 1 and 4 were present but of
larger size than 9Mi/I. In all three group II isolates, indels
consisted of small deletions and slightly larger insertions.
The IS 10 region, however, was quite unique in that PCR
products using primer pairs IS 10 and IS1111-1 produced
a product of incorrect size. Upon amplification with
primer pairs 1269R and 1273R, which correspond to
genes flanking the IS 10 element in 9Mi/I, products were
obtained. Sequence data indicated that the site where theBMC Microbiology 2007, 7:91 http://www.biomedcentral.com/1471-2180/7/91
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IS 10 primer anneals is missing due to a deletion of 1,650
bp in these isolates, but that the IS element is indeed
present.
Genomic group III isolate
A single isolate from genomic group III, Q195, was avail-
able in our repositories for analysis. There were no notice-
able differences in amplicon sizes between 9Mi/I and
Q195 for 15 of the 20 IS elements (2, 3, 5, 6, 7, 8, 9, 10,
12, 13, 15, 16, 17, 18, and 19). The only IS element which
Q195 lacked was IS 14. Sequencing of this region identi-
fied a genomic deletion of 1,374 bp.
Amplicons of larger size were produced to IS elements 1,
4 and 20. Upon sequencing of these PCR products, each
was missing 3 nucleotides and an identical sequence of 26
nucleotides was inserted in its place in all cases. The PCR
product for IS 11 was smaller for Q195 in comparison to
9Mi/I and was found to be lacking 8 bp.
Genomic group IV isolates
Two isolates from chronic Q fever patients exhibiting
endocarditis, KAV and PAV, have previously been placed
into group IV [4]. Q238 is believed to be an isolate derived
from the same patient as PAV, though it has not been gen-
otyped previously. These three isolates were examined by
PCR using the primer pairs to each of the 20 IS elements
described above. No amplicon size differences were seen
for 10 of the IS elements (2, 5, 6, 8, 11, 12, 13, 17, 19 and
20) when compared to 9Mi/I.
Analysis of IS 7 and IS 9 in the KAV, PAV and Q238 iso-
lates showed that both of these IS elements were missing.
Sequencing revealed the absence of 1,458 bp and 1,341
bp, respectively, compared to the IS 7 and IS 9 elements in
the 9Mi/I genome. Similarly, IS elements 14, 15, and 16
were missing in each of the genomic group IV isolates
because of identical deletions of 1,374 bp.
No products of the correct size were obtained from iso-
lates KAV, PAV and Q238 with primers for IS 10. A long
PCR product obtained using primers 1269R and 1273R
was sequenced and an IS element was found in this
region, although the annealing site for the IS 10 primer
was eliminated. The sequence of DNA to which the IS ele-
ment is connected corresponds to 9Mi/I nucleotide posi-
tions 1222860–1222964. The sequence is then
interrupted by 133 bp of sequence that does not match
sequence in 9Mi/I, but does match sequence found in the
Dugway 7E9-12 strain [GenBank: AAQI00000000].
Proposed algorithm flowchart and agarose gel photographs of corresponding PCR products Figure 1
Proposed algorithm flowchart and agarose gel photographs of corresponding PCR products. To discriminate isolates of C. bur-
netii using the algorithm shown, PCR is performed using the primer pairs depicted in boxes and negative PCR reactions allow 
for the discrimination of isolates into the genomic groups shown. Agarose gels of PCR products using primer pairs (from top 
to bottom) IS 9 and IS1111-1, IS 20 and IS1111-1, IS 5 and IS1111-1, and IS 14 and IS1111-1. Lanes 1, 100 bp ladder; 2, negative 
control; 3, 9Mi/I; 4, 9Mi/II; 5, RSA 514; 6, 9Mi/Baca; 7, Scottish; 8, Ohio; 9, Australian QD; 10, Q195; 11, Henz I; 12, Henz II; 13, 
M44; 14, KAV Q154; 15, PAV Q173; 16, Q238; 17, WAV.
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Products of IS 18-specific PCR in each of the three
genomic group IV isolates appeared to be slightly larger
than that of 9Mi/I. Upon sequencing of the KAV product,
however, this appeared to be a consequence of primer
mismatch to another IS element in the genome. The
sequence data obtained [GenBank: DQ882594] corre-
sponded to an IS element and a novel sequence not
present in the 9Mi/I genome. However, this sequence was
found in the Dugway 7E9-12 strain. Using long PCR to
flanking genes and DNA from the three isolates, no prod-
ucts were obtained, though PCR of each of the flanking
genes (data not shown) indicated they are present some-
where in the genome, suggesting that in these isolates, this
region of the genome has undergone rearrangement com-
pared to 9Mi/I.
PCR to IS elements 1, 3, and 4 produced products from
KAV, PAV and Q238 differing in size relative to 9Mi/I.
These variations were due to numerous indels ranging
from 1 bp to 32 bp. The indels in both IS 1 and IS 3
resulted in frame shifts in the predicted IS1111 encoded
protein.
Genomic group V isolate
WAV had not been characterized previously but was
hypothesized to be a member of genomic group V, as it
could be distinguished from each of the other isolates at a
variety of IS elements. It was indistinguishable from 9Mi/
I for 12 of the 20 IS elements (2, 3, 6, 8, 9, 10, 11, 12, 13,
16, 17, and 18). Six nucleotides were missing in WAV in
the products amplified from IS elements 1, 4, and 20
when compared to 9Mi/I and an identical 21-bp sequence
was present in its place in each case.
No amplicon was generated using primers to IS elements
5, 7, 14, 15 and 19. Sequencing confirmed the absence of
IS 5, 14 and 15 due to deletions of 1,374 bp, and of IS 7
due to a 1,458 bp deletion. Lastly, PCR to IS 19 using DNA
from WAV did not result in an amplicon. Long PCR using
primers 1960R and 1693R resulted in a product larger
than that from 9Mi/I (data not shown). Sequencing eluci-
dated that a rearrangement had occurred in this area of the
WAV genome, but was not pursued further as it was evi-
dent that an IS element was no longer present in this por-
tion of the WAV genome.
Creation and testing of an algorithm to differentiate C. 
burnetii strains
Using the information gained above, an algorithm was
derived which discriminated each of the five genomic
groups of isolates tested (Fig. 1). Because only group IV
heart valve isolates (KAV, PAV and Q238) lacked products
to IS 9, Henz I, Henz II, and M44 (group II) lacked IS 20,
and WAV (group V) lacked IS 5, PCR to these isolates
could be used to discriminate these groups. Isolates posi-
tive to each of these IS elements could then be further
tested using PCR to IS 14, which separates Q195 (group
III) isolates from group I isolates. PCR to IS 14 also serves
to confirm that group II, IV and V isolates, which also lack
this IS element, are grouped appropriately.
Further, each of the primer pairs used in the algorithm was
tested using a two-step PCR program, and all products
were successfully amplified (Fig. 1). The algorithm and
the two-step PCR was then tested with additional isolates
of C. burnetii and veterinary samples previously shown to
be PCR positive for the agent. This included two isolates
previously characterized, Priscilla Q177 (group IV) and
Q229 (group V), four isolates of unknown genomic group
(Idaho Q, Qiyi, Poker Cat and Q172), and nine veterinary
samples from a single outbreak in 2005 on a goat ranch in
Colorado. As expected, Priscilla Q177 and Q229 could be
differentiated appropriately due to the lack of PCR prod-
ucts when using primers to IS 9 and IS 5, respectively.
Q172 could also be placed into group V based on its lack
of product to IS 5. PCR to IS 14 was also negative in these
isolates, confirming that Priscilla Q177, Q229, and Q172
lacked this IS element as predicted. The remaining isolates
(Idaho Q, Qiyi and Poker Cat) produced PCR products
with all primer pairs and therefore were identical to 9Mi/
I in our assay and placed within group I (data not shown).
Six of the veterinary samples lacked PCR products to IS 9
and IS 14, placing them in genomic group IV. Three of the
veterinary samples, one from placenta and two from feces,
did not give PCR products using the above conditions.
Since these three samples were positive for C. burnetii
when tested with a real time-PCR assay that amplifies the
IS1111 element, it was suspected that an inhibitor was
present. By using a master mix that has demonstrated
increased sensitivity in our hands (PuReTaq Ready-To-Go
PCR Beads, GE Healthcare, Fairfield, CT) in lieu of Qiagen
Taq Master Mix, PCR products were successfully obtained
such that these samples were also shown to be members
of genomic group IV.
Discussion
In this study, PCR amplification and DNA sequencing of
the IS1111 transposase elements in the genome of C. bur-
netii and their surrounding sequence has been used to
extensively characterize these elements in multiple iso-
lates, and as target regions for inter- and intra-genomic
analysis. In some isolates, IS element PCR resulted in
products either larger or smaller than expected based on
the 9Mi/I genome and these were generally due to small
indels in the isolates tested. Numerous IS elements
present in the 9Mi/I genome were absent in the isolates
evaluated, mostly due to large deletions. Of the 25 dele-
tions which could be completely characterized by
sequencing, 16 were 1,374 in length. Larger deletions
were detected at IS 20 (2,246 bp) in the group II isolatesBMC Microbiology 2007, 7:91 http://www.biomedcentral.com/1471-2180/7/91
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and at IS 7 (1,458 bp) in the group IV and V isolates, while
a smaller deletion (1,341 bp) was detected at IS 9 in the
group IV isolates. The 1,374-bp length corresponds
exactly with the predicted length of the IS element [17],
demonstrating that the IS element has likely failed to inte-
grate into these sites thus far. The presence of larger dele-
tions may indicate that the IS element inserted into certain
sites and subsequently excised, taking additional genomic
sequence with it or causing genomic rearrangements
when doing so. Numerous nucleotide polymorphisms
were also seen in the stem-loop portion of the IS insertion
target sites (data not shown) which may render the sites
unrecognizable by the transposase, or alternatively, the IS
element simply may not have inserted into these IS recog-
nition sites. The sequence data demonstrate that, where
polymorphisms were noted, the stem of the stem-loop
structure is most times preserved while changes are evi-
dent in the loop region. An understanding of target site
recognition and insertion mechanisms will help to deter-
mine the importance of the nucleotides within the loop
region. If it is found that the overall structure but not spe-
cific nucleotide sequence is key to recognition, the divi-
sion of IS1111 into IS1111A, IS1111B and IS1111C, as
previously suggested based on sequence variation, may be
unnecessary [16].
Analysis of the M44 isolate was complicated by evidence
of a mixed population when analyzing IS 14. This result
could indicate that the isolate is truly a mixed population,
which is quite possible since it was never cloned. Previous
work from our laboratory supports this hypothesis, as
prior analysis of this isolate by an indirect immunofluo-
rescence assay demonstrated epitopes reactive with both
phase I- and phase II-specific antibodies [18]. However,
this result could also occur if IS1111 is actively transpos-
ing in the genome, in which case circular intermediates
should be detectable. PCR to determine if circular forms
of IS1111 were present in 9Mi/I did not result in a prod-
uct, though the linear form of IS1111  appeared to be
expressed as judged by reverse transcriptase-PCR analysis
(data not shown). It may be that expression of this linear
form leads to an actively transposing IS element at low
levels that we could not detect by PCR. The IS element
appears rather stable, however, in that all 9Mi/I derived
isolates have IS elements identically placed with no copies
having been eliminated, though additional copies could
be present and would not be detected by the methods
used in this study. Certainly further research into the
mechanism and frequency of IS1111 transposition is war-
ranted.
The inter-genomic comparisons based on our IS element
analysis showed very good correlation with RFLP analysis
that was previously used to divide C. burnetii isolates into
six distinct genomic groups [4]. Therefore, this analysis
was used to develop a PCR-based genotyping assay which
identifies an isolate as within one of the genomic groups,
I through V. The assay was effective in discriminating
genomic groupings in veterinary samples as well as puri-
fied isolates of C. burnetii. While most veterinary samples
could be differentiated using the conditions initially set
forth, an inhibitor was found to block amplification in
three of the veterinary samples, as PCR products to all IS
elements, even those conserved in all isolates tested, were
not produced. Inhibition was easily circumvented by
using a different master mix. It should be noted that inhi-
bition occurred with both of the fecal samples that were
tested. DNA from fecal samples is typically more difficult
to amplify due to the presence of inhibitors and other fac-
tors, and if DNA from feces will be used for genotyping,
extractions should be performed using protocols designed
especially for feces [19]. Therefore, it is recommended that
a control utilizing primers to a conserved IS element or a
housekeeping gene also be included in the run to check
for inhibition of the reaction. The DNA from any group I
isolate should be used as a positive size control in appli-
cations of the algorithm, as group I isolates produce a
product with all four algorithm primer pairs. Further, neg-
ative PCR results to any of the IS elements in the algo-
rithm should also be verified by sequencing the region to
ensure that mutations or deletions in primer binding
regions are not at fault and that the IS element is truly
lacking from this region. Sequencing of PCR products elu-
cidated single nucleotide polymorphisms in IS element
regions (data not shown) which could distinguish KAV
from PAV, though no differences were observed between
Henz I and Henz II or PAV and Q238. Sequencing was
also effective at determining which IS elements were being
amplified, and in some cases, sequences not found in the
9Mi/I genome were identified next to IS elements. It is
interesting to note that in the group IV isolates, IS 10 and
IS 18 primers annealed to sequences present in the Dug-
way 7E9-12 genome but not in Nine Mile. The origin of
the Dugway strain and how the group IV isolates came to
share genomic sequence with this strain, evolutionarily
speaking, is intriguing. While other genomic changes
undetectable by this method are surely present in these
isolates, which would allow for further discrimination of
isolates into a larger number of genotypes, the ability to
quickly identify members of genomic groups I through V
is useful. Perhaps a combination of rapid PCR-based
methods such as the algorithm presented here, and VNTR
(variable number tandem repeats) analysis [12,13] or
MLS (multispacer sequence) typing [11] for potentially
higher resolution, will prove optimal.
It is interesting to note that the Qiyi isolate, typed as
genomic group I in this study, was reportedly isolated
from the bone marrow of a patient with chronic Q fever
[20]. This represents a relatively novel finding, and sup-BMC Microbiology 2007, 7:91 http://www.biomedcentral.com/1471-2180/7/91
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ports a previous report that identified an isolate character-
ized as within genomic group I from a chronically infected
human in France [10]. In contrast, most isolates from
chronically infected humans have been classified into
genomic groups IV and V. Clearly, further examination of
the genomic composition and evolutionary relatedness of
isolates from both acute and chronic human infections is
warranted.
Conclusion
This study has begun to shed new light on the variations
of IS elements within the genome of multiple isolates and
the mechanism of IS element insertion in the C. burnetii
genome. It also presents an algorithm which may provide
a useful tool for grouping unknown isolates. Further, with
the additional use of sequencing in these regions, a multi-
tude of information can be learned about new isolates
which may be used to determine their relatedness to
known isolates of C. burnetii.
Methods
Bacterial isolates and veterinary samples
The isolates studied, their source, and passage history are
shown in Table 1. Isolates 9Mi/I, 9Mi/II, RSA 514, 9Mi/
Baca, Scottish, Ohio, Australian QD, Q195, Henz I, Henz
II, M44, KAV Q154, PAV Q173, Q238 and WAV, which
represent members of genomic groups I through V, were
initially used to create the algorithm presented below. Iso-
lates Priscilla Q177, Idaho Q, Qiyi, Poker Cat, Q229 and
Q172 were employed to test the algorithm, as were nine
veterinary samples from a single outbreak at a goat ranch
in Colorado in 2005. Of the nine samples, five were taken
from placental tissue, two from feces, and two from milk.
DNA isolation, PCR and sequencing analysis
DNA was extracted from purified bacteria or crude yolk
sac preparations using the QIAamp DNA Mini Kit (Qia-
gen, Valencia, CA). DNA was extracted from veterinary
samples using the QIAamp DNA Blood Kit (Qiagen), fol-
lowing the manufacturers protocol for extraction from tis-
sue samples. A PCR primer (IS1111-1) was designed to
anneal to a sequence conserved in all IS elements within
the 9Mi/I genome, and was paired with each of 20 primers
selected to bind to unique sequences approximately 500
bp upstream from each of the 20 IS elements. The
sequence of each primer used in this study is listed in
Table 2, along with the predicted amplicon size. For initial
screening as well as algorithm testing, PCR reactions were
performed in a 25 µl volume using the Qiagen Taq PCR
Master Mix kit, 0.2 µM of each primer, and 0.5 µl of tem-
Table 1: Original source and passage history of C. burnetii isolates used in this study.
Genomic group
RFLPa IS1111 PCRb Plasmid type Isolate (Phase)c Original source Passage historyd
I I QpH1 9Mi/I/C7 (I) Montana, tick, 1935 307GP/1TC/1EP
I I QpH1 9Mi/II/C4 (II) Montana, tick, 1935 304GP/90EP/1TC/4EP
I I QpH1 9Mi/RSA 514 (II) Montana, tick, 1935 307GP/1TC/1EP/343 days GP/5EP
I I QpH1 Ohio (I) Ohio, cow's milk, 1956 5EP/2GP/2EP
I I QpH1 Australian QD (II) Australia, human blood, ~1939 177EP
NDe I QpH1 Scottish (ND) Unknown Unknown
ND I QpH1 Idaho Q (ND) Unknown Unknown
ND I ND 9Mi/Baca (II) Montana, tick, 1935 307GP/1TC/1EP/4091 days TC
II II QpH1 Henzerling RSA 343 (I) Italy, human blood, 1945 6GP/25EP/1GP/4EP
II II QpH1 Henzerling RSA 331 (II) Italy, human blood, 1945 6GP/25EP/1GP/36EP
II II QpH1 M44 (II) Greece, human blood, ~1945 1GP/86EP/20GP/50MP/5EP
III III QpH1 Q195 (ND) Idaho, goat Unknown
IV IV QpRS KAV Q154 (I) Oregon, human heart valve, 1976 1GP/3EP
IV IV QpRS PAV Q173 (I) California, human heart valve, 1979 2EP
IV IV QpRS Priscilla Q177 (I) Montana, goat cotyledon, 1980 Unknown
ND IV QpRS Q238 (ND) Human heart valve, 1979 3EP
V V Plasmidless Q229 (I) Human heart valve, 1982 Unknown
ND V ND WAV (ND) Human heart valve Unknown
ND V ND Q172 (ND) Human placenta 3MP/2EP
ND I ND Qiyi (ND) China, human bone marrow, 1962 Unknown
ND I ND Poker Cat (ND) Nova Scotia, 1987 Unknown
a As determined in previous studies [4, 5].
b As determined in this study.
c Phase of isolate as determined by complement block titration, M.G. Peacock, Rocky Mountain Laboratories, Hamilton, Montana [4].
d Numbers indicate passage in: GP, guinea pig; TC, tissue culture; EP, embryonated eggs; MP, mice
e Not determinedBMC Microbiology 2007, 7:91 http://www.biomedcentral.com/1471-2180/7/91
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plate DNA. For initial screenings, PCR cycling conditions
consisted of an initial denaturation at 95°C for 3 min, 35
cycles each consisting of 30 s at temperatures of 95°C,
55°C, and 72°C, and a final extension for 7 min at 72°C.
Reactions testing the algorithm (IS elements 5, 9, 14 and
20) utilized 2 µl of template DNA and were subjected to
cycling conditions of an initial denaturation at 95°C for 3
min, 40 cycles each consisting of 30 s at temperatures of
95°C and 68°C, and a final extension for 7 min at 72°C.
PCR products were visualized using ethidium bromide-
stained 1.2% agarose gels.
For isolates which lacked specific IS elements, the
upstream primer was paired with additional PCR primers
(see Table 2) to adjacent downstream genes based on the
9Mi/I genome sequence [GenBank: AE016828]. In some
instances, new upstream primers were also needed to
determine the extent of the deleted DNA (IS10, IS18 and
IS19), sometimes resulting in large PCR amplicons. When
PCR amplicons were predicted to be larger than 1.5 kb,
long PCR was performed. These reactions were carried out
in 25 µl volumes using Extensor High-Fidelity PCR Master
Mix (ABgene Inc. USA, Rochester, NY), 0.2 µM of each
primer, and 0.5 µl of template DNA. PCR cycling condi-
tions consisted of an initial denaturation at 94°C for 2
min, 10 cycles each consisting of 94°C for 10 sec, 55°C
for 30 sec, and 68°C for 8 min, followed by 20 cycles each
consisting of 94°C for 10 sec, 55°C for 30 sec, and 68°C
for 8 min +10 sec/cycle, with a final extension for 7 min at
68°C. Products were visualized using ethidium bromide-
stained 0.8% agarose gels.
In instances where amplicons were of a different size than
those present in 9Mi/I or where products were obtained
using primers to genes adjacent to a missing IS element,
DNA sequencing was performed. PCR products obtained
above were processed through a DNA Clean & Concentra-
tor-5 column (Zymo Research Corp., Orange, CA) and
Table 2: Primers, their target, sequence, primer pairings and predicted amplicon size of primer pair.
Target Primer name Sequence (5' to 3') Paired primer set and predicted amplicon size
Conserved for each IS element IS1111-1 ACTGCGTTGGGATACCCATC NAa
IS1 IS1 TAATGGGCGACCAAGTCGA IS1111-1; 501 bp
IS2 IS2 GGCTGAATGAATGCCTTCCA IS1111-1; 501 bp
IS3 IS3 AAAAAGACCCTTCAGGTAATGGAA IS1111-1; 477 bp
IS4 IS4 TTCCGCCATGACCAACTTC IS1111-1; 519 bp
IS5 IS5 GTCGGTCAACGTCGTCACAT IS1111-1; 515 bp
556F AACCGTGGCTGAGCGATC IS5; NA
IS6 IS6 CCATTTGCAATAGCCGTGAA IS1111-1; 477 bp
IS7 IS7 GCGGTTTTGGTACAATACTGTCATT IS1111-1; 571 bp
1091F TGCAGGACATATTGTTGATGTCAC IS7; NA
IS8 IS8 GGCAAGGATGACGAATGGAT IS1111-1; 471 bp
IS9 IS9 GCCTCAGCCGATTTCGAG IS1111-1; 492 bp
1219F CCCGAAGGTATCCATAACTCTGG IS9; NA
IS10 IS10 GTGCGGCATTCGTGGTAGA IS1111-1; 481 bp
1269R GATTTCCATCGACGTCCGC 1273R; NA
1273R TTCAGTTTATAGCGGCAGGACC IS1111-1; NA
IS11 IS11 AAAGCCGTTCCCTACCGTG IS1111-1; 481 bp
IS12 IS12 ACGTAGTTTGGAAAGGATACCCG IS1111-1; 482 bp
IS13 IS13 GATGAGCGTCCACCACTGAA IS1111-1; 537 bp
IS14 IS14 TGCTACCAACAGACTTACGGCA IS1111-1; 481 bp
1701R TAAACACGAGGCGCTAGGTCA IS14; NA
IS15 IS15 AACGCCCATGTGAGAAACATC IS1111-1; 531 bp
1718F ACGGGTGTTCAAGCAGCC IS15; NA
IS16 IS16 ATGACTTCTGATAGGGACTGTGCTC IS1111-1; 511 bp
1761F GCCGTTGATCTTGCCGATAA IS16; NA
IS17 IS17 CGAATCGCATTGGCACAGT IS1111-1; 477 bp
IS18 IS18 CGTTTGCTGCTATACGACATGAA IS1111-1; 532 bp
IS19 IS19 GTCGCCCAGGAGTGTTTCTG IS1111-1; 531 bp
1960R ACAAAGACGACTCAGTTCGGC 1963R; NA
1963R CGATGTCTGCCTTTAGGAGGTC 1960R; NA
1963R-seq GTAGAAAGAGTCTCTCTTG NA
IS20 IS20 ACGTCAATTACATCGAGCATTCA IS1111-1; 470 bp
1987F AGGGCCATCTTGACCTGGA 1993F; NA
1993F CGCACTGAGCGCATTGAC 1987F; NA
a Not applicableBMC Microbiology 2007, 7:91 http://www.biomedcentral.com/1471-2180/7/91
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eluted in 16 µl of water. Sequencing reactions were per-
formed with 1 µl of purified PCR product, one of the
primers used to generate that PCR product, and the
BigDye Terminator v3.1 Cycle Sequencing kit (Applied
Biosystems, Foster City, CA). Unincorporated dye termi-
nators were removed with a DyeEx 2.0 Spin Kit (Qiagen),
the eluate was dried in a vacuum centrifuge, and the pellet
suspended in 10 ul of Hi-Di formamide (Applied Biosys-
tems). Sequencing reactions were analyzed in an ABI
Prism 3100 Genetic Analyzer, and the Genetics Computer
Group Wisconsin Package Version 10.3 (Accelrys Inc., San
Diego, CA) was used for subsequent analysis of DNA
sequences.
Authors' contributions
AMD carried out all experimental elements of the study
and drafted the manuscript. HAT and RFM conceived the
study, participated in its design and helped to draft the
manuscript. All authors have read and approved the final
manuscript.
Additional material
Acknowledgements
We thank Jonathan Arzt (Veterinary Diagnostic Laboratory, Colorado 
State University) for providing the veterinary samples used in this study and 
Rachael Priestley for extracting DNA from the veterinary samples.
This research was supported in part by the appointment of A.M.D. to the 
ASM Post-Doctoral ResearchFellowship Program in Infectious Diseases 
and Public Health Microbiologysupported by the Centers for Disease Con-
trol and Prevention and administered by the American Society for Microbi-
ology, as well as the appointment of A.M.D. to the Research Participation 
Program at the Centers for Disease Control and Prevention, Coordinating 
Center for Infectious Diseases, Division of Viral and Rickettsial Diseases, 
administered by the Oak Ridge Institute for Science and Education through 
an interagency agreement between the U.S. Department of Energy and 
CDC.
The findings and conclusions in this report are those of the authors and do 
not necessarily represent the views of the CDC or the Department of 
Health and Human Services.
References
1. Benenson AS, Tigertt WD: Studies on Q fever in man.  Trans Assoc
Am Physicians 1956, 69:98-104.
2. Raoult D, Marrie T, Mege J: Natural history and pathophysiology
of Q fever.  Lancet Infect Dis 2005, 5:219-226.
3. Vodkin MH, Williams JC, Stephenson EH: Genetic heterogeneity
among isolates of Coxiella burnetii.  J Gen Microbiol 1986,
132:455-463.
4. Hendrix LR, Samuel JE, Mallavia LP: Differentiation of Coxiella
burnetii isolates by analysis of restriction-endonuclease-
digested DNA separated by SDS-PAGE.  J Gen Microbiol 1991,
137:269-276.
5. Heinzen R, Stiegler GL, Whiting LL, Schmitt SA, Mallavia LP, Frazier
ME: Use of pulsed field gel electrophoresis to differentiate
Coxiella burnetii strains.  Ann N Y Acad Sci 1990, 590:504-513.
6. Willems H, Ritter M, Jager C, Thiele D: Plasmid-homologous
sequences in the chromosome of plasmidless Coxiella bur-
netii Scurry Q217.  J Bacteriol 1997, 179:3293-3297.
7. Savinelli EA, Mallavia LP: Comparison of Coxiella burnetii plas-
mids to homologous chromosomal sequences present in a
plasmidless endocarditis-causing isolate.  Ann N Y Acad Sci 1990,
590:523-533.
8. Stoenner HG, Lackman DB: The biologic properties of Coxiella
burnetii isolated from rodents collected in Utah.  Am J Hyg
1960, 71:45-51.
9. Jager C, Lautenschlager S, Willems H, Baljer G: Coxiella burnetii
plasmid types QpDG and QpH1 are closely related and likely
identical.  Vet Microbiol 2002, 89:161-166.
10. Jager C, Willems H, Thiele D, Baljer G: Molecular characteriza-
tion of Coxiella burnetii isolates.  Epidemiol Infect 1998,
120:157-164.
11. Glazunova O, Roux V, Freylikman O, Sekeyova Z, Fournous G, Tyc-
zka J, Tokarevich N, Kovacava E, Marrie TJ, Raoult D: Coxiella bur-
netii genotyping.  Emerg Infect Dis 2005, 11:1211-1217.
12. Arricau-Bouvery N, Hauck Y, Bejaoui A, Frangoulidis D, Bodier CC,
Souriau A, Meyer H, Neubauer H, Rodolakis A, Vergnaud G: Molec-
ular characterization of Coxiella burnetii isolates by infre-
quent restriction site-PCR and MLVA typing.  BMC Microbiol
2006, 6:38.
13. Svraka S, Toman R, Skultety L, Slaba K, Homan WL: Establishment
of a genotyping scheme for Coxiella burnetii.  FEMS Microbiol
Lett 2006, 254:268-274.
14. Beare PA, Samuel JE, Howe D, Virtaneva K, Porcella SF, Heinzen RA:
Genetic diversity of the Q fever agent, Coxiella burnetii,
assessed by microarray-based whole-genome comparisons.  J
Bacteriol 2006, 188:2309-2324.
15. Seshadri R, Paulsen IT, Eisen JA, Read TD, Nelson KE, Nelson WC,
Ward NL, Tettelin H, Davidsen TM, Beanan MJ, Deboy RT, Daugh-
erty SC, Brinkac LM, Madupu R, Dodson RJ, Khouri HM, Lee KH,
Carty HA, Scanlan D, Heinzen RA, Thompson HA, Samuel JE, Fraser
CM, Heidelberg JF: Complete genome sequence of the Q-fever
pathogen Coxiella burnetii.  Proc Natl Acad Sci USA 2003,
100:5455-5460.
16. Hoover TA, Vodkin MH, Williams JC: A Coxiella burnetii
repeated DNA element resembling a bacterial insertion
sequence.  J Bacteriol 1992, 174:5540-5548.
17. Partridge SR, Hall RM: The IS1111 family members IS4321 and
IS5075 have subterminal inverted repeats and target the ter-
minal inverted repeats of Tn21 family transposons.  J Bacteriol
2003, 185:6371-6384.
18. Denison AM, Massung RF, Thompson HA: Analysis of the O-anti-
gen biosynthesis regions of phase II Isolates of Coxiella bur-
netii.  FEMS Microbiol Lett 2007, 267:102-107.
19. Zhang BW, Li M, Ma LC, Wei FW: A widely applicable protocol
for DNA isolation from fecal samples.  Biochem Genet 2006,
44:494-503.
20. Ning Z, Yu SR, Quan YG, Xue Z: Molecular characterization of
cloned variants of Coxiella burnetii isolated in China.  Acta
Virol 1992, 36:173-183.
Additional file 1
Presence (+) or absence (-) of IS elements in various isolates of C. bur-
netii; Table includes a description of each of the 20 IS elements and notes 
whether the element was present or absent in each of the isolates tested, as 
well as Genbank accession numbers for deletions and mutations discov-
ered during this study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2180-7-91-S1.xls]